ILLUCCIX

Serial Number 79297402
Registration 6549629
700

Registration Progress

Application Filed
Aug 27, 2020
Under Examination
Approved for Publication
Aug 24, 2021
Published for Opposition
Aug 24, 2021
Registered
Nov 9, 2021

Trademark Image

ILLUCCIX

Basic Information

Serial Number
79297402
Registration Number
6549629
Filing Date
August 27, 2020
Registration Date
November 9, 2021
Published for Opposition
August 24, 2021
Drawing Code
4000

Status Summary

Current Status
Active
Status Code
700
Status Date
Nov 9, 2021
Registration
Registered
Classes
005 010

Rights Holder

Telix Pharmaceuticals Limited

99
Address
Suite 401,
55 Flemington Road North Melbourne VIC 3
AU

Ownership History

Telix Pharmaceuticals Limited

Original Applicant
99
AU

Telix Pharmaceuticals Limited

Owner at Publication
99
AU

Telix Pharmaceuticals Limited

Original Registrant
99
AU

Legal Representation

Attorney
Andrew S. Ehard

USPTO Deadlines

Next Deadline
689 days remaining
Section 71 Declaration Due (Principal Register 66a) (Based on registration date 20211109)
Due Date
November 09, 2027
Grace Period Ends
May 09, 2028
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

26 events
Date Code Type Description Documents
Aug 14, 2022 NREP P NEW REPRESENTATIVE AT IB RECEIVED Loading...
May 24, 2022 FINO P FINAL DECISION TRANSACTION PROCESSED BY IB Loading...
Apr 29, 2022 FICS P FINAL DISPOSITION NOTICE SENT TO IB Loading...
Apr 28, 2022 FIMP P FINAL DISPOSITION PROCESSED Loading...
Feb 9, 2022 FICR P FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Loading...
Nov 9, 2021 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Aug 24, 2021 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Aug 24, 2021 PUBO A PUBLISHED FOR OPPOSITION Loading...
Aug 22, 2021 GPNX P NOTIFICATION PROCESSED BY IB Loading...
Aug 4, 2021 OPNS P NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Loading...
Aug 4, 2021 OP2R P NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Loading...
Aug 4, 2021 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jul 20, 2021 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jul 16, 2021 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jul 16, 2021 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jul 16, 2021 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Feb 7, 2021 RFNT P REFUSAL PROCESSED BY IB Loading...
Jan 20, 2021 RFCS P NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Loading...
Jan 20, 2021 RFRR P REFUSAL PROCESSED BY MPU Loading...
Jan 5, 2021 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Dec 31, 2020 RFCR E NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Loading...
Dec 30, 2020 CNRT R NON-FINAL ACTION WRITTEN Loading...
Dec 30, 2020 DOCK D ASSIGNED TO EXAMINER Loading...
Dec 30, 2020 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Dec 28, 2020 LIMI I LIMITATION FROM ORIGINAL APPLICATION ENTERED Loading...
Nov 5, 2020 REPR M SN ASSIGNED FOR SECT 66A APPL FROM IB Loading...

Detailed Classifications

Class 005
Chemical preparations for pharmaceutical purposes, namely, diagnostic radiopharmaceutical preparations; pharmaceutical preparations for the imaging, diagnosing and monitoring of cancer; pharmaceutical preparations for the treatment of cancer; radiopharmaceutical imaging and detection agents for use in the imaging, diagnosing and monitoring of cancer
First Use Anywhere: 0
First Use in Commerce: 0
Class 010
Medical apparatus, namely, infusion and injection devices for administering drugs and diagnostic radiopharmaceuticals; apparatus for medical purposes, namely, drug delivery devices sold empty, namely, syringes and infusion sets for diagnostic radiopharmaceuticals; medical devices for treating cancer; diagnostic imaging apparatus for medical use
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005 010